Dramatic Recovery of Vision after Trastuzumab Deruxtecan Treatment of HER2-Positive Breast Cancer with Pituitary Metastasis

In recent years, both the number of patients with breast cancer and those with associated brain metastases (BMs) have increased. Human epidermal growth factor receptor 2 (HER2)-positive breast cancer has a high BM frequency. The prognosis of BM from breast cancer is poor, and establishing effective...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Chiaki Matsui, Nobuhiro Shibata, Chie Hirai, Manami Tada, Yuichiro Kikawa, Tomoharu Sugie
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Karger Publishers 2023-07-01
Schriftenreihe:	Case Reports in Oncology
Schlagworte:	breast cancer brain metastases her2 vision loss trastuzumab deruxtecan
Online-Zugang:	https://beta.karger.com/Article/FullText/531164
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!